| # | Drug | Count |
|---|---|---|
| 0 | ZIDOVUDINE | 37 |
| 1 | CABOTEGRAVIR | 28 |
| 2 | RILPIVIRINE | 27 |
| 3 | PREDNISOLONE | 26 |
| 4 | PREDNISOLONE ORAL | 26 |
| 5 | PREDNISOLONE ORAL SOLUTION | 26 |
| 6 | VALACYCLOVIR | 22 |
| 7 | VALACYCLOVIR HYDROCHLORIDE | 22 |
| 8 | AZATHIOPRINE | 20 |
| 9 | VALGANCICLOVIR | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 3 | 0.0062 |
| 1 | RILPIVIRINE | 27 | 0.0038 |
| 2 | ZIDOVUDINE | 37 | 0.0036 |
| 3 | CABOTEGRAVIR | 28 | 0.0034 |
| 4 | CEFUROXIME SODIUM | 2 | 0.0016 |
| 5 | CEFUROXIME | 14 | 0.0012 |
| 6 | VALGANCICLOVIR | 20 | 0.0010 |
| 7 | NELFINAVIR MESYLATE | 2 | 0.0010 |
| 8 | LAMIVUDINE AND ZIDOVUDINE | 5 | 0.0006 |
| 9 | RALTEGRAVIR | 3 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 21 | 0.0009 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 41 | 0.0004 |
| 2 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 11 | 0.0002 |
| 4 | Purine Antimetabolite [EPC] | 20 | 0.0002 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 6 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 17 | 0.0001 |
| 7 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 17 | 0.0001 |
| 8 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |